ANTIBACTERIAL TREATMENT OF ACUTE BACTERIAL DISEASES OF THE UPPER RESPIRATORY TRACT IN CHILDREN

Abstract

For acute respiratory viral infections (ARVI) in children, antibacterial therapy is required in only 6-8% of cases accompanied by bacterial complications. This article discusses only lesions of the upper respiratory tract and some types of bronchitis (caused by mycoplasma and chlamydia), for which the prescription of antibacterial agents is indicated. Unfortunately, the frequency of prescription of antimicrobial drugs in children with acute respiratory viral infections significantly exceeds this figure, reaching 65-85% in clinics and 98% in hospitals, and antibacterial agents are administered parenterally in clinics in more than 40%, and in hospitals - in 70% cases [1,2]. With this approach, there are 39 injections per inpatient with uncomplicated ARVI (laryngitis, bronchitis), and 74 per patient with acute pneumonia.